162 related articles for article (PubMed ID: 34446018)
1. Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register.
Ceriello A; Lucisano G; Prattichizzo F; Eliasson B; Franzén S; Svensson AM; Nicolucci A
Cardiovasc Diabetol; 2021 Aug; 20(1):173. PubMed ID: 34446018
[TBL] [Abstract][Full Text] [Related]
2. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target.
Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Svensson AM; Eliasson B; Nicolucci A
Cardiovasc Diabetol; 2022 Jan; 21(1):13. PubMed ID: 35073913
[TBL] [Abstract][Full Text] [Related]
3. Risk factor variability and cardiovascular risk among patients with diabetes: a nationwide observational study.
Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Gudbjörnsdottir S; Eliasson B; Nicolucci A
Eur J Prev Cardiol; 2023 Jun; 30(8):719-727. PubMed ID: 36897149
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.
Adamsson Eryd S; Gudbjörnsdottir S; Manhem K; Rosengren A; Svensson AM; Miftaraj M; Franzén S; Björck S
BMJ; 2016 Aug; 354():i4070. PubMed ID: 27492939
[TBL] [Abstract][Full Text] [Related]
5. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register.
Svensson MK; Cederholm J; Eliasson B; Zethelius B; Gudbjörnsdottir S;
Diab Vasc Dis Res; 2013 Nov; 10(6):520-9. PubMed ID: 24002670
[TBL] [Abstract][Full Text] [Related]
6. Body Weight Variability and the Risk of Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes: A Nationwide Cohort Study.
Nam GE; Kim W; Han K; Lee CW; Kwon Y; Han B; Park S; Park JH; Kim YH; Kim DH; Kim SM; Choi YS; Cho KH; Park YG
Diabetes Care; 2020 Sep; 43(9):2234-2241. PubMed ID: 32641375
[TBL] [Abstract][Full Text] [Related]
7. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study.
Rawshani A; Sattar N; Franzén S; Rawshani A; Hattersley AT; Svensson AM; Eliasson B; Gudbjörnsdottir S
Lancet; 2018 Aug; 392(10146):477-486. PubMed ID: 30129464
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Salles GF
Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
[TBL] [Abstract][Full Text] [Related]
9. Mortality rates and cardiovascular disease burden in type 2 diabetes by occupation, results from all Swedish employees in 2002-2015.
Carlsson S; Andersson T; Talbäck M; Feychting M
Cardiovasc Diabetol; 2021 Jun; 20(1):129. PubMed ID: 34174883
[TBL] [Abstract][Full Text] [Related]
10. Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register.
Zethelius B; Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K; Cederholm J;
Eur J Prev Cardiol; 2014 Feb; 21(2):244-51. PubMed ID: 24227183
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.
Ohkuma T; Woodward M; Jun M; Muntner P; Hata J; Colagiuri S; Harrap S; Mancia G; Poulter N; Williams B; Rothwell P; Chalmers J;
Hypertension; 2017 Aug; 70(2):461-468. PubMed ID: 28584014
[TBL] [Abstract][Full Text] [Related]
12. Nationwide comparison of long-term survival and cardiovascular morbidity after acute aortic aneurysm repair in patients with and without type 2 diabetes.
Taimour S; Franzén S; Zarrouk M; Acosta S; Nilsson P; Miftaraj M; Eliasson B; Svensson AM; Gottsäter A
J Vasc Surg; 2020 Jan; 71(1):30-38.e3. PubMed ID: 31068268
[TBL] [Abstract][Full Text] [Related]
13. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Nunez L; Gudbjörnsdóttir S; Eliasson B
Diabetologia; 2009 Jan; 52(1):65-73. PubMed ID: 18985314
[TBL] [Abstract][Full Text] [Related]
14. BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox.
Edqvist J; Rawshani A; Adiels M; Björck L; Lind M; Svensson AM; Gudbjörnsdottir S; Sattar N; Rosengren A
Diabetes Care; 2019 Jul; 42(7):1297-1304. PubMed ID: 31048408
[TBL] [Abstract][Full Text] [Related]
15. High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study.
Lee HJ; Choi EK; Han KD; Kim DH; Lee E; Lee SR; Oh S; Lip GYH
Cardiovasc Diabetol; 2020 Jun; 19(1):78. PubMed ID: 32534567
[TBL] [Abstract][Full Text] [Related]
16. Weight change and mortality and cardiovascular outcomes in patients with new-onset diabetes mellitus: a nationwide cohort study.
Kim MK; Han K; Koh ES; Kim ES; Lee MK; Nam GE; Kwon HS
Cardiovasc Diabetol; 2019 Mar; 18(1):36. PubMed ID: 30890169
[TBL] [Abstract][Full Text] [Related]
17. Weight variability and cardiovascular outcomes: a systematic review and meta-analysis.
Massey RJ; Siddiqui MK; Pearson ER; Dawed AY
Cardiovasc Diabetol; 2023 Jan; 22(1):5. PubMed ID: 36624453
[TBL] [Abstract][Full Text] [Related]
18. Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden.
Svanström H; Ueda P; Melbye M; Eliasson B; Svensson AM; Franzén S; Gudbjörnsdottir S; Hveem K; Jonasson C; Pasternak B
Lancet Diabetes Endocrinol; 2019 Feb; 7(2):106-114. PubMed ID: 30527909
[TBL] [Abstract][Full Text] [Related]
19. Long-term Survival and Cardiovascular Morbidity after Elective Open Aortic Aneurysm Repair in Patients with and without Type 2 Diabetes: A Nationwide Propensity-Adjusted Analysis.
Zarrouk M; Franzén S; Acosta S; Nilsson P; Miftaraj M; Eliasson B; Svensson AM; Gottsäter A
Ann Vasc Surg; 2019 Aug; 59():110-118. PubMed ID: 31029685
[TBL] [Abstract][Full Text] [Related]
20. C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. The Skaraborg diabetes register.
Pikkemaat M; Andersson T; Melander O; Chalmers J; Rådholm K; Bengtsson Boström K
Diabetes Res Clin Pract; 2019 Apr; 150():174-183. PubMed ID: 30878389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
